Name: Pfizer's defense in the whistleblower case, most of which did not expect
Uploaded: 2023-02-07T06:57:09+00:00
Duration: 2 min
Description: Pfizer's defense in the whistleblower case, most of which did not expect: "We were not obliged to produce a safe and effective product. " On January 24, 2023, Katherine Watt participated in a press co

1 year ago

223

pfizer whistleblower case bioweapon katherine watt emergency use

Pfizer's defense in the whistleblower case, most of which did not expect: "We were not obliged to produce a safe and effective product. "

On January 24, 2023, Katherine Watt participated in a press conference discussing the ongoing introduction of bioweapons for emergency use marketed as Covid vaccines. It discussed the legal framework in which this is happening and identified ways to avoid WHO/BIS/DOD initiatives that undermine sovereignty.

To follow their work and ongoing research, please visit: https://bailiwicknews.substack.com/